PDL Biopharma

Drugmakers master rolling out their own generics to stifle competition
Drugmakers master rolling out their own generics to stifle competition
Fierce Pharma
generics
PDL Biopharma
Tekturna
Hatch Waxman Act
Flag link:
PDL gets aggressive with an offer to buy out Neos Therapeutics
PDL gets aggressive with an offer to buy out Neos Therapeutics
Endpoints
PDL Biopharma
Neos Therapeutics
M&A
Flag link:
Biotech Movers: Sarepta, Paratek, PDL BioPharma
Biotech Movers: Sarepta, Paratek, PDL BioPharma
TheStreet.com
Sarepta Therapeutics
Exondys 5
Paratek
omadacycline
PDL Biopharma
patents
Merck
Keytruda
Flag link:
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
Motley Fool
biotech
Amgen
Gilead Sciences
PDL Biopharma
Flag link:
3 Small Biotechs That Look Very Healthy
3 Small Biotechs That Look Very Healthy
TheStreet.com
PDL Biopharma
Five Prime
Anika Therapeutics
Flag link:
How Patent Risk Poses a Big Threat to PDL BioPharma
How Patent Risk Poses a Big Threat to PDL BioPharma
Motley Fool
PDL Biopharma
patents
Flag link:
The Worst 3 Biotech Stocks for 2016
The Worst 3 Biotech Stocks for 2016
Motley Fool
biotech
Arena Pharmaceuticals
PDL Biopharma
MannKind
Flag link:
Is Valeant Headed For Financial Trouble Or Merely Ignorant Of Its Contractual Obligations?
Is Valeant Headed For Financial Trouble Or Merely Ignorant Of Its Contractual Obligations?
Seeking Alpha
Valeant Pharmaceuticals
PDL Biopharma
Flag link:
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Fierce Biotech
Ariad Pharmaceuticals
R&D
Iclusig
acute lymphoblastic leukemia
PDL Biopharma
Flag link:
PDL BioPharma: Watch Out For The Big Revenue Drop Coming
PDL BioPharma: Watch Out For The Big Revenue Drop Coming
Seeking Alpha
PDL Biopharma
earnings
Flag link:
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against PDL BioPharma, Inc. -- PDLI
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against PDL BioPharma, Inc. -- PDLI
Yahoo/Globe NewsWire
PDL Biopharma
lawsuits
Flag link:
3 Biotech Dividend Darlings for Your Portfolio
3 Biotech Dividend Darlings for Your Portfolio
Motley Fool
Amgen
PDL Biopharma
Teva Pharmaceuticals
Flag link:
PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative
PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative
Seeking Alpha
PDL Biopharma
Roche
Genentech
Avastin
Herceptin
Lucentis Xolair
Kadcyla
Perjeta
Lucentis
Flag link:
PDL Biopharma says it settled Roche royalty fight
PDL Biopharma says it settled Roche royalty fight
Yahoo/AP
PDL Biopharma
Roche
Avastin
Herceptin
Kadcyla
Perjeta
Lucentis
Xolair
Flag link:
Avinger draws new financing to back testing of light-enhanced PAD catheter
Avinger draws new financing to back testing of light-enhanced PAD catheter
Fierce Medical Devices
peripheral artery disease
PDL Biopharma
PAD catheter
devices
Avinger
Flag link:
This Week in Biotech: Twitter Edition
This Week in Biotech: Twitter Edition
Motley Fool
Gilead Sciences
PDL Biopharma
Depomed
Vertex Pharmaceuticals
JNJ
Sarepta Therapeutics
Flag link:
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Yahoo
diabetes
Depomed
PDL Biopharma
Flag link:
PDL BioPharma Provides $60 Million in Financing to LENSAR
PDL BioPharma Provides $60 Million in Financing to LENSAR
Yahoo
PDL Biopharma
LensAR
refractive cataract surgery
devices
Flag link:
PDL BioPharma says 3Q revenue climbed 14 percent
PDL BioPharma says 3Q revenue climbed 14 percent
Yahoo/AP
earnings
PDL Biopharma
Flag link:
Earnings for PDL BioPharma (PDLI) Projected to Rise
Earnings for PDL BioPharma (PDLI) Projected to Rise
Forbes
PDL Biopharma
earnings
Flag link:

Pages